A detailed history of Plante Moran Financial Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 37 shares of BIIB stock, worth $6,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 17 117.65%
Holding current value
$6,430
Previous $3,000 133.33%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$189.07 - $236.8 $3,781 - $4,736
20 Added 117.65%
37 $7,000
Q1 2024

May 09, 2024

SELL
$212.02 - $267.71 $1,484 - $1,873
-7 Reduced 29.17%
17 $3,000
Q4 2023

Feb 05, 2024

BUY
$222.59 - $267.94 $1,558 - $1,875
7 Added 41.18%
24 $6,000
Q2 2023

Aug 07, 2023

SELL
$275.25 - $318.06 $30,277 - $34,986
-110 Reduced 86.61%
17 $4,000
Q1 2022

May 06, 2022

SELL
$193.77 - $244.14 $19,764 - $24,902
-102 Reduced 44.54%
127 $27,000
Q4 2021

Feb 09, 2022

SELL
$223.92 - $287.77 $7,389 - $9,496
-33 Reduced 12.6%
229 $55,000
Q3 2021

Nov 08, 2021

BUY
$282.99 - $369.05 $13,583 - $17,714
48 Added 22.43%
262 $74,000
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $14,577 - $17,077
-60 Reduced 21.9%
214 $60,000
Q4 2020

Feb 09, 2021

SELL
$236.26 - $355.63 $4,961 - $7,468
-21 Reduced 7.12%
274 $67,000
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $12,179 - $14,062
-46 Reduced 13.49%
295 $84,000
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $6,725 - $8,906
-26 Reduced 7.08%
341 $91,000
Q1 2020

May 07, 2020

BUY
$268.85 - $341.04 $22,583 - $28,647
84 Added 29.68%
367 $116,000
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $5,501 - $7,601
-25 Reduced 8.12%
283 $84,000
Q3 2019

Nov 13, 2019

BUY
$217.44 - $243.88 $8,915 - $9,999
41 Added 15.36%
308 $71,000
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $3,947 - $4,350
-18 Reduced 6.32%
267 $62,000
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $2,383 - $3,728
-11 Reduced 3.72%
285 $67,000
Q4 2018

Jan 29, 2019

SELL
$278.5 - $352.75 $18,102 - $22,928
-65 Reduced 18.01%
296 $89,000
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $19,665 - $25,716
67 Added 22.79%
361 $128,000
Q2 2018

Jul 26, 2018

SELL
$257.52 - $306.91 $13,391 - $15,959
-52 Reduced 15.03%
294 $85,000
Q1 2018

May 01, 2018

BUY
$260.13 - $367.91 $8,064 - $11,405
31 Added 9.84%
346 $95,000
Q3 2017

Nov 08, 2017

BUY
$281.15 - $329.69 $88,562 - $103,852
315
315 $99,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.